Express Scripts Holding Co (ESRX.O)
61.87USD
17 May 2013
$1.17 (+1.93%)
$60.70
$61.00
$61.91
$60.89
5,161,801
5,729,963
$66.06
$49.79
About
Overall
| Beta: | 1.04 |
| Market Cap (Mil.): | $50,580.52 |
| Shares Outstanding (Mil.): | 817.53 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| ESRX.O | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 39.43 | 19.37 | 41.15 |
| EPS (TTM): | 1.57 | -- | -- |
| ROI: | 5.06 | 9.84 | 80.39 |
| ROE: | 10.96 | 11.07 | 88.65 |
BRIEF-CVS still "very confident" can keep 60 pct of scripts from Walgreen-Express Scripts spat
May 1 - CVS Caremark Corp : * Still "very confident" can keep at least 60 percent of scripts in 2013 gained
Express Scripts quarterly profit tops Wall Street estimate
- Express Scripts Holding Co on Monday reported higher-than-expected first-quarter earnings, helped by greater use of more profitable generic medicines, and the pharmacy benefit manager raised its full-year forecast.
UPDATE 2-Express Scripts profit tops Wall St view, ups forecast
April 29 - Express Scripts Holding Co on Monday reported higher-than-expected first-quarter earnings, helped by greater use of more profitable generic medicines, and the pharmacy benefit manager raised its full-year forecast.
Express Scripts quarterly profit tops Wall Street view
April 29 - Pharmacy benefit manager Express Scripts Holding Co on Monday reported higher-than-expected first quarter earnings, helped by greater use of more profitable generic medicines.
Fitch Affirms Express Scripts Holdings' IDR at 'BBB'; Outlook Revised to Stable
(The following statement was released by the rating agency) CHICAGO, March 27 (Fitch) Fitch Ratings has affirmed the Issuer Default Ratings (IDRs) of Express Scripts Holdings (NYSE: ESRX) and its subsidiaries (Express Scripts, Inc. and Medco Health Solutions, Inc. ) at 'BBB'. The ratings apply to roughly $15.7 billion in debt, and Fitch has revised the Rating Outlooks for all three IDRs to Stable from Negative. A complete list of ESRX's ratings can be found at the end of this press release.
Express Scripts accuses Ernst & Young of stealing trade secrets
- A unit of Express Scripts Holding Co has sued Ernst & Young and one of the accounting firm's former partners for stealing trade secrets and corporate data to boost Ernst & Young's own healthcare business.
Express Scripts accuses Ernst & Young of stealing trade secrets
* Suit says Ernst & Young partner took over 20,000 pages of data
BRIEF-Express Scripts up in premarket after results
NEW YORK, Feb 19 - Express Scripts Holding Co : * Shares up 5.3 percent in premarket trading after results
AmerisourceBergen net up as new contract boosts revs
- Pharmaceutical distributor AmerisourceBergen Corp said on Thursday that quarterly earnings rose as revenue was boosted after it won a contract with giant pharmacy benefit manager Express Scripts earlier this year.
UPDATE 2-AmerisourceBergen net up as new contract boosts revs
Jan 24 - Pharmaceutical distributor AmerisourceBergen Corp said on Thursday that quarterly earnings rose as revenue was boosted after it won a contract with giant pharmacy benefit manager Express Scripts earlier this year.
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Jefferson Research
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

